Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Sign in
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Emerging Approaches in Schizophrenia
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
View All
Letter to the Editor
Page 169
Recently published articles about
Letter to the Editor
JCP
Letter to the Editor
Reversible Dyskinesia During Bupropion Therapy
May 15, 1997
George Gardos
JCP
Letter to the Editor
Benztropine in the Treatment of Venlafaxine-Induced Sweating
April 15, 1997
Aaron Garber
,
Robert J. Gregory
JCP
Letter to the Editor
Bupropion for SSRI-Induced Fatigue
April 15, 1997
Thomas R. Green
JCP
Letter to the Editor
Impact of a Smoking Ban on a Locked Psychiatric Unit
April 15, 1997
Theodore Pearlman
JCP
Letter to the Editor
Novel Use of Tramadol Hydrochloride in the Treatment of Tourette's Syndrome
April 15, 1997
Nathan A. Shapira
,
Brian J. McConville
,
M. Lisa Pagnucco
, et al
JCP
Letter to the Editor
Pharmacologic Properties of Venlafaxine
April 15, 1997
Mary N. Smith
«
1
…
167
168
169
170
171
…
173
»
